Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-01-25Clinical Trial Update: Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression [Phase 1]
A Phase 1 clinical trial evaluating yoga as an intervention for people at risk for diabetes or with HIV infection and depression has complet…
-
CLINICAL_TRIALS trial_result · 2008-01-17Clinical Trial Update: Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression [Phase 3]
Phase 3 trial evaluating Ethyl-EPA for major depressive disorder has completed; the snippet does not provide results.
-
FDA approval · 2008-01-16FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA granted supplemental approval for Amneal Pharmaceuticals of New York LLC's generic bupropion hydrochloride (ANDA076711). The document in…
-
CLINICAL_TRIALS trial_result · 2008-01-15Clinical Trial Update: Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder [Phase 2]
A Phase 2 flexible-dose titration add-on trial for major depressive disorder sponsored by Targacept has completed.
-
FDA approval · 2008-01-11FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for a sertraline generic product from Heritage Pharmaceuticals (Avet), authorizing changes to the ap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2008-01-08Clinical Trial Update: The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder [NA]
A clinical trial evaluating agomelatine or fluoxentine on heart rate variability in patients with major depressive disorder has been withdra…
-
FDA approval · 2008-01-08FDA Approved: SERTRALINE HYDROCHLORIDE — Original Application (Granules Pharmaceuticals Inc.)
FDA approved Granules Pharmaceuticals Inc.'s sertraline hydrochloride generic under an Original Application. The approval provides a generic…
-
CLINICAL_TRIALS trial_result · 2008-01-07Clinical Trial Update: Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients [Phase 4]
Phase 4 trial results comparing fixed doses of escitalopram to an active comparator in adults with severe major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder [Phase 3]
Clinical trial update notes that a Phase 3 study of desvenlafaxine sustained-release (DVS-SR) for adults with major depressive disorder has …
-
CLINICAL_TRIALS trial_result · 2007-12-28Clinical Trial Update: Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway [Phase 1]
Phase 1 study evaluating DVS SR for inhibiting the CYP2D6 pathway has completed, sponsored by Wyeth (Pfizer).
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression [NA]
A terminated clinical trial evaluating pindolol augmentation in patients taking venlafaxine for major depressive disorder.
-
CLINICAL_TRIALS trial_result · 2007-12-27Clinical Trial Update: Fibromyalgia in Men Suffering From PTSD
This clinical trial update reports the completion of a study evaluating fibromyalgia in men with posttraumatic stress disorder, with comorbi…
-
FDA approval · 2007-12-26FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for SERTRALINE HYDROCHLORIDE (generic) from Aurobindo Pharma Limited, updating the regulatory status…
-
FDA approval · 2007-12-14FDA Approved: EFFEXOR XR — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Effexor XR (venlafaxine hydrochloride) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS research · 2007-12-14Clinical Trial Update: Reducing Depressive Symptoms During HCV Therapy: A Randomized Study [NA]
A randomized clinical trial update evaluating strategies to reduce depressive symptoms in people undergoing hepatitis C therapy.
-
FDA approval · 2007-12-12FDA Approved: TRANYLCYPROMINE SULFATE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental ANDA for Tranylcypromine Sulfate, enabling Strides Pharma Science Limited to market a generic version of this MA…
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Drug Treatment for Depressed Alcoholics (Naltrexone/Fluoxetine) [Phase 4]
Phase 4 clinical trial evaluating the combination of naltrexone and fluoxetine for individuals with alcohol use disorder and comorbid depres…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects [Phase 3]
Phase 3 study update evaluating how DVS SR and paroxetine affect the pharmacokinetics of desipramine in healthy subjects; the trial is compl…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity [Phase 1]
Phase 1 study examining the effects of an acute dose of bupropion on neural substrates of hedonic capacity in major depressive disorder. The…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Prevalence of Depression and Anxiety in Patients Seeking Medical Care at General Health Care Settings in China
This completed clinical trial assessed how common depression and anxiety are among adults seeking medical care in general health care settin…
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: STILDEP: Zolpidem in Depressive and Dysthimic Patients [Phase 4]
Sanofi-sponsored Phase 4 trial evaluating zolpidem in patients with insomnia and depressive disorders (including dysthymia) has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-06Clinical Trial Update: Behavioral Processes Underlying Reward Processing in Depression
A completed ClinicalTrials.gov study by Affective Neuroscience Laboratory examined reward processing in depression, including major depressi…
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder [Phase 3]
A Phase 3 clinical trial evaluating desvenlafaxine tablets for adult outpatients with major depressive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2007-12-05Clinical Trial Update: Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR) [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of a single dose of Desvenlafaxine Sustained Release (DVS SR) in major depressive d…
-
FDA approval · 2007-11-28FDA Approved: DESIPRAMINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for desipramine hydrochloride from Actavis Pharma, Inc. This action finalizes the approval of a gene…